← SynDRA
CGP-60474
SynDRA canonical compound SYN1966955 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | CDK1 | CDK2 |
| Mechanism of action | CDK inhibitor |
All known targets
Mechanisms of action (all sources)
- cyclin-dependent kinase inhibitor
Cross-references
Synonyms
- CGP 60474
- CGP60474
- UNII-16IP6G5MLC
- GNF-Pf-88
- 16IP6G5MLC
- 3-[[4-[2-[(3-Chlorophenyl)amino]-4-pyrimidinyl]-2-pyridinyl]amino]-1-propanol
- MLS000911536
- SMR000463552
- 3-[[4-[2-(3-chloroanilino)pyrimidin-4-yl]-2-pyridyl]amino]propan-1-ol
- 3-[[4-[2-(3-chloroanilino)pyrimidin-4-yl]pyridin-2-yl]amino]propan-1-ol
- 1-Propanol, 3-((4-(2-((3-chlorophenyl)amino)-4-pyrimidinyl)-2-pyridinyl)amino)-
- 1-propanol, 3-[[4-[2-[(3-chlorophenyl)amino]-4-pyrimidinyl]-2-pyridinyl]amino]-
- AC1LD8S6
- MLS003105942
Look up CGP-60474 in the interactive SynDRA portal →